Advanced search
Publication Cover
Cancer Investigation Volume 37, 2019 - Issue 8
Submit an article Journal homepage
87
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Aspirin Use and Risk of Ovarian Cancer: More Player Pathways for a Common Starting Point?

Raffaella MormileDivision of Pediatrics and Neonatology, Moscati Hospital, Aversa, ItalyCorrespondence[email protected]
Pages 415-416 | Received 04 Nov 2018, Accepted 04 Aug 2019, Published online: 26 Aug 2019

References

  • Minlikeeva AN, Moysich KB. An aspirin a day keeps ovarian cancer at bay? Expert Rev Anticancer Ther. 2019; 19(7):541–2.
  • Seewaldt VL. Aspirin and chemoprevention-have we arrived? JAMA Oncol. 2018; 4(12):1668–9. doi:10.1001/jamaoncol.2018.4138.
  • Wield AM, Walsh CS, Rimel BJ, Cass I, Karlan BY, Li AJ. Aspirin use correlates with survival in women with clear cell ovarian cancer. Gynecol Oncol Rep. 2018;25:78–81. doi:10.1016/j.gore.2018.06.004.
  • Jin M, Li C, Zhang Q, Xing S, Kan X, Wang J. Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-κB/survivin signaling pathway. Oncol Lett. 2018;15(6):8454–60. doi:10.3892/ol.2018.8377.
  • Jiang JH, Lv QY, Yi YX, Liao J, Wang XW, Zhang W. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN. Eur Rev Med Pharmacol Sci. 2018;22(19):6260–7.
  • Russo A, Czarnecki AA, Dean M, Modi DA, Lantvit DD, Hardy L, et al. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Oncogene. 2018;37(15):1976–90. doi:10.1038/s41388-017-0097-8.
  • He X, Yang K, Wang H, Chen X, Wu H, Yao L, et al. Expression and clinical significance of survivin in ovarian cancer: a meta-analysis. PLoS One. 2018;13(5):e0194463. doi:10.1371/journal.pone.0194463.
  • Yanagisawa S, Baker JR, Vuppusetty C, Fenwick P, Donnelly LE, Ito K, et al. Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L230–9. doi:10.1152/ajplung.00382.2016.
  • Browning L, Patel MR, Horvath EB, Tawara K, Jorcyk CL. IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis. CMAR.. 2018; 10:6685–93. doi:10.2147/CMAR.S179189.
  • Westfall SD, Skinner MK. Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment. Mol Cancer Ther. 2005;4(11):1764–71. doi:10.1158/1535-7163.MCT-05-0192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.